biotech

Ignite It
1 min read • April 30, 2025

“Trump’s Pick To Lead DEA Says Marijuana Rescheduling Review Will Be ‘One Of My First Priorities’ In The Job” – Marijuana Moment

Ignite It
1 min read • April 22, 2025

Reported Earlier: ‘Texas Lawmakers Take Up Bills To Expedite Access To Psychedelic Therapy’ – Marijuana Moment

Ignite It
1 min read • April 17, 2025

‘Bipartisan Congressional Lawmakers File Bill To End Federal Marijuana Prohibition In Legal States In Line With Trump’s Stance’ – Marijuana Moment

Ignite It
1 min read • March 12, 2025

‘Nevada Senators Take Up Resolution Calling On Congress To Reschedule Psychedelics And Streamline Research’ – Marijuana Moment

Ignite It
3 min read • March 6, 2025

Cannabis For Pain Relief: Scientists Develop New Compound Without Mind-Altering Effects — Alternative To Opioids?

Ignite It
1 min read • February 24, 2025

‘Senator John Fetterman Circulates Petition To Legalize Marijuana At The Federal Level’ – Marijuana Moment

Ignite It
1 min read • February 14, 2025

Artelo Biosciences Presented Nonclinical Results On ART12.11 At International Medical Cannabis Conference

Ignite It
1 min read • February 11, 2025

Artelo Biosciences Will Be Presenting Data On ART12.11, A Proprietary Cocrystal Composed Of Cannabidiol And Tetramethylpyrazine , At The International Medical Cannabis Conference , February 13-14, 2025

Ignite It
1 min read • February 10, 2025

“DEA Official Says Marijuana Rescheduling Is ‘Delayed, But Certainly Not Dead'” – The Marijuana Herald

Ignite It
7 min read • February 5, 2025

Cannabis Takes On Superbugs: Could This New Drug ‘Change Infection Treatment Forever’?

Ignite It
3 min read • January 28, 2025

How Ozempic And Legal Weed Are Changing What America Eats

Ignite It
2 min read • December 23, 2024

Anebulo Pharmaceuticals Announces FDA Feedback For IV Selonabant To Address Cannabis-Induced Toxicity In Children And Completes $15M Capital Raise; Phase I Study Planned For 1H25

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.